BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 2423882)

  • 1. Mechanism of membrane damage mediated by human eosinophil cationic protein.
    Young JD; Peterson CG; Venge P; Cohn ZA
    Nature; 1986 Jun 5-11; 321(6070):613-6. PubMed ID: 2423882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergism between eosinophil cationic protein and oxygen metabolites in killing of schistosomula of Schistosoma mansoni.
    Yazdanbakhsh M; Tai PC; Spry CJ; Gleich GJ; Roos D
    J Immunol; 1987 May; 138(10):3443-7. PubMed ID: 3571976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein.
    Lehrer RI; Szklarek D; Barton A; Ganz T; Hamann KJ; Gleich GJ
    J Immunol; 1989 Jun; 142(12):4428-34. PubMed ID: 2656865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophil granule proteins activate human heart mast cells.
    Patella V; de Crescenzo G; Marinò I; Genovese A; Adt M; Gleich GJ; Marone G
    J Immunol; 1996 Aug; 157(3):1219-25. PubMed ID: 8757629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative toxicity of purified human eosinophil granule proteins for newborn larvae of Trichinella spiralis.
    Hamann KJ; Barker RL; Loegering DA; Gleich GJ
    J Parasitol; 1987 Jun; 73(3):523-9. PubMed ID: 3598802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative toxicity of purified human eosinophil granule cationic proteins for schistosomula of Schistosoma mansoni.
    Ackerman SJ; Gleich GJ; Loegering DA; Richardson BA; Butterworth AE
    Am J Trop Med Hyg; 1985 Jul; 34(4):735-45. PubMed ID: 4025686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro killing of microfilariae of Brugia pahangi and Brugia malayi by eosinophil granule proteins.
    Hamann KJ; Gleich GJ; Checkel JL; Loegering DA; McCall JW; Barker RL
    J Immunol; 1990 Apr; 144(8):3166-73. PubMed ID: 2324497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein.
    Slifman NR; Loegering DA; McKean DJ; Gleich GJ
    J Immunol; 1986 Nov; 137(9):2913-7. PubMed ID: 3760576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin.
    Ackerman SJ; Loegering DA; Venge P; Olsson I; Harley JB; Fauci AS; Gleich GJ
    J Immunol; 1983 Dec; 131(6):2977-82. PubMed ID: 6644025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of human eosinophil granule major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin by immunoelectron microscopy.
    Peters MS; Rodriguez M; Gleich GJ
    Lab Invest; 1986 Jun; 54(6):656-62. PubMed ID: 3520144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both aromatic and cationic residues contribute to the membrane-lytic and bactericidal activity of eosinophil cationic protein.
    Carreras E; Boix E; Rosenberg HF; Cuchillo CM; Nogués MV
    Biochemistry; 2003 Jun; 42(22):6636-44. PubMed ID: 12779318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial purification and biological properties of an eosinophil-activating factor.
    Thorne KJ; Richardson BA; Veith MC; Tai PC; Spry CJ; Butterworth AE
    Eur J Immunol; 1985 Nov; 15(11):1083-91. PubMed ID: 2998804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils.
    Kita H; Abu-Ghazaleh RI; Sur S; Gleich GJ
    J Immunol; 1995 May; 154(9):4749-58. PubMed ID: 7722326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophil cationic protein cDNA. Comparison with other toxic cationic proteins and ribonucleases.
    Barker RL; Loegering DA; Ten RM; Hamann KJ; Pease LR; Gleich GJ
    J Immunol; 1989 Aug; 143(3):952-5. PubMed ID: 2745977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein.
    Torpier G; Colombel JF; Mathieu-Chandelier C; Capron M; Dessaint JP; Cortot A; Paris JC; Capron A
    Clin Exp Immunol; 1988 Dec; 74(3):404-8. PubMed ID: 3233790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human B-cell growth-inhibitory activity of eosinophil cationic protein.
    Kimata H; Yoshida A; Ishioka C; Jiang Y; Mikawa H
    Biotechnol Ther; 1992; 3(3-4):137-49. PubMed ID: 1303727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies to human eosinophil plasma membrane antigens enhance the secretion of eosinophil cationic protein.
    Tai PC; Capron M; Bakes DM; Barkans J; Spry CJ
    Clin Exp Immunol; 1986 Mar; 63(3):728-37. PubMed ID: 3708911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory syncytial virus-infected pulmonary epithelial cells induce eosinophil degranulation by a CD18-mediated mechanism.
    Olszewska-Pazdrak B; Pazdrak K; Ogra PL; Garofalo RP
    J Immunol; 1998 May; 160(10):4889-95. PubMed ID: 9590236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins.
    Zheutlin LM; Ackerman SJ; Gleich GJ; Thomas LL
    J Immunol; 1984 Oct; 133(4):2180-5. PubMed ID: 6206154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens.
    Rosenberg HF; Domachowske JB
    J Leukoc Biol; 2001 Nov; 70(5):691-8. PubMed ID: 11698487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.